# A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

> **NCT02565108** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 20 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** GWP42003-P 20 mg/kg/Day Dose
- **DRUG:** Placebo
- **DRUG:** Clobazam

## Key facts

- **NCT ID:** NCT02565108
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-20
- **Primary completion:** 2016-07-21
- **Final completion:** 2016-07-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565108, "A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02565108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*